semaglutide blood in urine patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Semaglutide-associated kidney injury - PMC

Riesgos en poblaciones vulnerables: Existen casos documentados de bacteriemia, fungemia y sepsis asociadas a probiticos en pacientes inmunocomprometidos, con catteres venosos centrales, enfermedad intestinal inflamatoria severa o sndrome de intestino corto

Nutritional intervention is an important first step that emphasizes a low-calorie and low-fat diet that stimulates excessive insulin demands

When used alongside semaglutide, which can independently cause tachycardia and palpitations in some patients, the combined cardiovascular burden rises significantly

Whether that broader coverage is valuable depends on the specific research question